[New biological treatments for lung cancer]. [electronic resource]
Producer: 20070618Description: 20-8 p. digitalISSN:- 0761-8417
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Bevacizumab
- Biopsy
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Forecasting
- Gefitinib
- Humans
- Lung -- pathology
- Lung Neoplasms -- drug therapy
- Male
- Mutation
- Patient Selection
- Polymerase Chain Reaction
- Prospective Studies
- Protein Kinase Inhibitors -- administration & dosage
- Quinazolines -- administration & dosage
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Survival Analysis
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.